Claudio Castaños

605 total citations
33 papers, 354 citations indexed

About

Claudio Castaños is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Physiology. According to data from OpenAlex, Claudio Castaños has authored 33 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 12 papers in Surgery and 12 papers in Physiology. Recurrent topics in Claudio Castaños's work include Cystic Fibrosis Research Advances (13 papers), Neonatal Respiratory Health Research (8 papers) and Asthma and respiratory diseases (8 papers). Claudio Castaños is often cited by papers focused on Cystic Fibrosis Research Advances (13 papers), Neonatal Respiratory Health Research (8 papers) and Asthma and respiratory diseases (8 papers). Claudio Castaños collaborates with scholars based in Argentina, United States and Chile. Claudio Castaños's co-authors include Verónica Giubergia, Patricia Murtagh, J. Goldberg, Antonio Latella, Jorge Braier, Lilien Chertkoff, Guillermo Chantada, Diego Rosso, Luisa Sen and Andrea Mangano and has published in prestigious journals such as The Lancet Respiratory Medicine, Acta Paediatrica and Journal of Clinical Immunology.

In The Last Decade

Claudio Castaños

31 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Castaños Argentina 10 217 144 129 56 49 33 354
J. Pfeffer Israel 5 215 1.0× 199 1.4× 63 0.5× 37 0.7× 69 1.4× 12 399
Jennifer A Kynaston Australia 10 258 1.2× 250 1.7× 44 0.3× 25 0.4× 43 0.9× 16 416
Verónica Giubergia Argentina 9 152 0.7× 45 0.3× 138 1.1× 32 0.6× 82 1.7× 23 264
Patrick Stafler Israel 11 263 1.2× 52 0.4× 85 0.7× 67 1.2× 147 3.0× 41 433
R. Ross‐Russell United Kingdom 7 217 1.0× 85 0.6× 81 0.6× 23 0.4× 83 1.7× 12 341
O Linna Finland 10 227 1.0× 243 1.7× 80 0.6× 39 0.7× 81 1.7× 31 457
Adèle Coriati Canada 14 459 2.1× 58 0.4× 228 1.8× 21 0.4× 25 0.5× 39 677
Keiichi Akasaka Japan 12 243 1.1× 70 0.5× 80 0.6× 13 0.2× 54 1.1× 41 353
Ioanna Loukou Greece 13 284 1.3× 119 0.8× 33 0.3× 26 0.5× 45 0.9× 44 420
Joanna Peradzyńska Poland 9 163 0.8× 103 0.7× 35 0.3× 22 0.4× 88 1.8× 20 283

Countries citing papers authored by Claudio Castaños

Since Specialization
Citations

This map shows the geographic impact of Claudio Castaños's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Castaños with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Castaños more than expected).

Fields of papers citing papers by Claudio Castaños

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Castaños. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Castaños. The network helps show where Claudio Castaños may publish in the future.

Co-authorship network of co-authors of Claudio Castaños

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Castaños. A scholar is included among the top collaborators of Claudio Castaños based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Castaños. Claudio Castaños is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giubergia, Verónica, et al.. (2024). Childhood severe asthma: relationship among asthma control scores, FeNO, spirometry and impulse oscillometry. BMC Pulmonary Medicine. 24(1). 270–270. 3 indexed citations
2.
Castaños, Claudio, et al.. (2023). Clinical and functional course of patients with cystic fibrosis treated with lumacaftor/ivacaftor at a children’s hospital. A case series. Archivos Argentinos de Pediatria. 121(5). e202202825–e202202825. 1 indexed citations
3.
Castaños, Claudio, et al.. (2023). Pulmonary surfactant metabolism dysfunction: A pediatric clinical case report. Archivos Argentinos de Pediatria. 122(3). e202310084–e202310084.
4.
Castaños, Claudio. (2023). The past 10 years of cystic fibrosis treatment: the road to cure. The Lancet Respiratory Medicine. 11(10). 864–865. 1 indexed citations
5.
Rosain, Jérémie, Andrea Bernasconi, Tom Le Voyer, et al.. (2022). Pulmonary Alveolar Proteinosis and Multiple Infectious Diseases in a Child with Autosomal Recessive Complete IRF8 Deficiency. Journal of Clinical Immunology. 42(5). 975–985. 8 indexed citations
6.
Garrahan, Juan P., et al.. (2019). Impacto clínico del tratamiento con omalizumab en niños con asma grave. Reporte de una experiencia local. Archivos Argentinos de Pediatria. 117(2).
7.
Giubergia, Verónica, et al.. (2019). Clinical impact of omalizumab treatment in children with severe asthma. Report of a local experience. Archivos Argentinos de Pediatria. 117(2). e115–e120. 6 indexed citations
8.
Esteban, Ignacio, et al.. (2019). Neumonía bullosa secundaria a Elizabethkingia meningoseptica, su evolución clínica y radiológica. Archivos Argentinos de Pediatria. 117(2). e150–e154. 2 indexed citations
9.
Guidó, Paulo Cáceres, et al.. (2019). Population pharmacokinetics of amikacin in patients with pediatric cystic fibrosis. Pediatric Pulmonology. 54(11). 1801–1810. 10 indexed citations
10.
Castaños, Claudio, et al.. (2018). Asma grave en pediatría: resultados de la implementación de un protocolo especial de atención. Archivos Argentinos de Pediatria. 116(2). 2 indexed citations
11.
Giubergia, Verónica, et al.. (2016). Risk factors for morbidities and mortality in children following pneumonectomy. Respirology. 22(1). 187–191. 8 indexed citations
12.
Giubergia, Verónica, et al.. (2015). Post‐infectious bronchiolitis obliterans and mannose‐binding lectin insufficiency in Argentinean children. Respirology. 20(6). 982–986. 11 indexed citations
13.
Castro‐Rodríguez, José A., Verónica Giubergia, Gilberto Bueno Fischer, et al.. (2014). Postinfectious bronchiolitis obliterans in children: the South American contribution. Acta Paediatrica. 103(9). 913–921. 29 indexed citations
14.
Sen, Luisa, et al.. (2014). Mannose-binding lectin gene as a modifier of the cystic fibrosis phenotype in Argentinean pediatric patients. Journal of Cystic Fibrosis. 14(1). 78–83. 9 indexed citations
15.
Smith, Steven A., et al.. (2014). WS3.5 Inhaled 7% hypertonic saline treatment in preschool children with cystic fibrosis. Journal of Cystic Fibrosis. 13. S7–S7. 4 indexed citations
16.
Castaños, Claudio, et al.. (2010). Postinfectious bronchiolitis obliterans in children: Clinical and pulmonary function findings. Pediatric Pulmonology. 45(12). 1180–1185. 44 indexed citations
17.
Castaños, Claudio, et al.. (2008). [Dehydration and metabolic alkalosis: an unusual presentation of cystic fibrosis in an infant].. PubMed. 106(5). 443–6. 5 indexed citations
18.
Braier, Jorge, et al.. (2005). Isolated pulmonary Langerhans cell histiocytosis presenting with recurrent pneumothorax. Pediatric Blood & Cancer. 48(2). 241–244. 20 indexed citations
19.
Ferrero, Fernando, et al.. (2004). Prevalencia del consumo de tabaco en médicos residentes de pediatría en Argentina. Revista Panamericana de Salud Pública. 15(6). 395–399. 9 indexed citations
20.
Braier, Jorge, Antonio Latella, Claudio Castaños, et al.. (2004). Outcome in children with pulmonary Langerhans cell histiocytosis. Pediatric Blood & Cancer. 43(7). 765–769. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Pfeffer Breakdown of academic impact, for papers by Jennifer A Kynaston Breakdown of academic impact, for papers by Verónica Giubergia Breakdown of academic impact, for papers by Patrick Stafler Breakdown of academic impact, for papers by R. Ross‐Russell Breakdown of academic impact, for papers by O Linna Breakdown of academic impact, for papers by Adèle Coriati Breakdown of academic impact, for papers by Keiichi Akasaka Breakdown of academic impact, for papers by Ioanna Loukou Breakdown of academic impact, for papers by Joanna Peradzyńska
Rankless by CCL
2026